Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by DJDawgon Dec 16, 2021 5:54pm
536 Views
Post# 34238743

Pattern in news releases

Pattern in news releases
Hi

I was skimming the website and saw that the Indian Patent PR was actually dated mid November. Yet it wasn't really released till Dec 9. It seems to me that they likely knew about the patent and had the approval and ability to release it mid Nov but purposely held it back.

In sequence, they have released
Mid Nov- info on the hiring of Vera
End Nov - the quarterly with the good patient's CR updates.
Dec 9 - the PR on the India patent approval.

It seems to me that they are actually trying to parcel out the news updates, as in being strategic about it. Not sure if it means anything. Could they be trying to build some news momentum every few weeks to try to build share price a bit? Not sure. Any longholders with opinions? My only reason to ask is that it seems funny to release the India patent Dec 9 update with a PR that is actually dated mid Nov.

Discuss away! :)
<< Previous
Bullboard Posts
Next >>